News
Investing.com -- Inovio Pharmaceuticals Inc (NASDAQ: INO) stock plunged 14% after the company announced plans for an underwritten public offering of its common stock and warrants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback